The most popular stories and special reports in FierceBiotech Research, FiercePharmaManufacturing, and the rest of our Life Sciences publications

We hope you've found this year's roundup of the most popular content on the web interesting. Below, you'll find the top-visited stories, slideshows and special reports from each of our weekly and semi-weekly publications this year. The content is listed by popularity in descending order.

We'll be back on Monday with our regular coverage. Enjoy the leftovers.

Suggested Articles

Yale scientists have combined the gene-editing system CRISPR with gene therapy to help the immune system find tough-to-spot tumor cells.

The planned deal hit a wall when a special committee set up by Eidos turned down BridgeBio’s third and final offer.

Shares in ReNeuron fell more than one-third after the release of top-line data at the start of the month but the biotech argued the data are positive.